Elevated hormone flags liver problems in mice with methylmalonic acidemia
Thursday, December 6, 2018
Elevated hormone flags liver problems in mice with methylmalonic acidemia

Researchers have discovered that a hormone, fibroblast growth factor 21 (FGF21), is extremely elevated in mice with liver disease that mimics the same condition in patients with (MMA), a serious genomic disorder. Based on this finding, medical teams treating patients with MMA will be able to measure FGF21 levels to predict how severely patients鈥 livers are affected and when to refer patients for liver transplants. The findings also might shed light on more common disorders such as fatty liver disease, obesity and diabetes by uncovering similarities in how MMA and these disorders affect energy metabolism and, more specifically, the function of mitochondria, the cells鈥 energy powerhouses. The study, conducted by researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, was published Dec. 6 in JCI Insight.
鈥淔indings from mouse studies usually take years to translate into health care treatment, but not in this case,鈥 said , M.D., Ph.D., senior author and senior investigator in the NHGRI Medical Genomics and Metabolic Genetics Branch. 鈥淲e can use this information today to ensure that patients with MMA are treated before they develop severe complications.鈥
MMA is a genomic disease that impairs a person鈥檚 ability to break down food proteins and certain fatty acids. The condition affects roughly 1 in 50,000 children born in the United States and can be detected through newborn screening. Children with MMA suffer from frequent life-threatening metabolic crises when they encounter a minor viral illness or other stressors like trauma, dietary imbalance or surgery. They must adhere to a special low-protein diet and take various supplements their entire lives.
The NHGRI team created a new mouse model and used it to discover key pathways that were affected during a fasting challenge to model a metabolic crisis in a patient with MMA. It enabled them to identify markers that they could then measure in MMA patients to assess the severity of the dysfunction in their mitochondria, specifically in the liver.
The MMA mice also allowed them to study the response to liver-directed gene therapy and to compare the findings in patients after liver transplant surgery. Liver transplants give patients with MMA a missing enzyme and ease some of the symptoms, but do not cure the disease. Kidney transplantation, on the other hand, is necessary when these patients reach terminal stages of renal failure, an expected chronic complication of MMA. Selecting which patients would benefit from a liver or combined liver/kidney transplant as opposed to just a kidney transplant is an important clinical decision for families and their clinicians.
鈥淲e found that having MMA, whether in a mouse or person, causes stress pathways to be chronically activated and can impair their ability to respond to acute stress,鈥 said Irini Manoli, M.D., Ph.D., lead author and associate investigator in NHGRI鈥檚 Medical Genomics and Metabolic Genetics Branch. 鈥淥ur new markers can accurately predict how effective a therapy, whether cellular or genomic, might be for the patients.鈥
The NHGRI team will use FGF21 measurements along with other tests presented in the study in the design of upcoming gene-based that the lab has worked on for many years. The NHGRI team will next assess the role of FGF21 pathways in other symptoms seen in MMA. Since 2003, Dr. Venditti and his team have conducted research on patients with MMA and are following 200 patients with MMA, the world鈥檚 largest cohort. Their goals are to understand what defines the vulnerability to stress in MMA to better diagnose life-threatening metabolic crises that occur in patients, test new genomic therapies and find treatments that work for every patient.
NHGRI is the driving force for advancing genomics research at the National Institutes of Health. By conducting and funding world-class genomics research, training the next generation of genomics experts, and collaborating with diverse communities, NHGRI accelerates scientific and medical breakthroughs that improve human health. Learn more at .
About the National Institutes of Health (51视频): 51视频, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. 51视频 is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about 51视频 and its programs, visit www.nih.gov.
51视频鈥urning Discovery Into Health庐
Institute/Center
Contact
301-402-0911